中文版 | English
题名

Dynamic differentiation of F4/80+tumor-associated macrophage and its role in tumor vascularization in a syngeneic mouse model of colorectal liver metastasis

作者
通讯作者Zhang, Jian; Leng, Jing; Ren, Huan
发表日期
2023-02-13
DOI
发表期刊
ISSN
2041-4889
卷号14期号:2
摘要
Tumor-associated macrophages (TAMs) are highly heterogeneous and play vital roles in tumor progression. Here we adopted a C57BL/6 mouse model imitating the late-stage colorectal liver metastasis (CRLM) by Mc38 colorectal cancer cell injection via the portal vein. With serial sections of CRLM biopsies, we defined 7-9 days post-injection as the critical period for tumor neovascularization, which was initiated from the innate liver vessels via vessel cooption and extended by vascular mimicry and thereof growth of CD34(+)cells. In samples with increasing-sized liver metastases, the infiltrated Ly6C(+) CD11b(+) F4/80(-) monocytes steadily gained the expression of F4/80, a Kupffer cell marker, before transformed into Ly6C(-) CD11b(int) F4/80(+) cells, which, the same phenotype was also adapted by Ly6C(-) CD11b(-) F4/80(+) Kupffer cells. F4/80(+) TAMs showed proximity to neovascularization and tumor vessels, functionally angiogenic in vivo; and greatly promoted the activation of a few key angiogenic markers such as VEGFA, Ki67, etc. in endothelial cells in vitro. Depletion of macrophages or diversion of macrophage polarization during neovascularization impeded tumor growth and vascularization and resulted in greatly reduced F4/80(+) TAMs, yet increased CD11b(+) cells due to inhibition of TAM differentiation. In summary, our results showed dynamic and spatial-temporal F4/80(+) TAM transformation within the tumor microenvironment and strengthened its role as perivascular and angiogenic TAMs in CRLM.
相关链接[来源记录]
收录类别
语种
英语
学校署名
第一 ; 通讯
资助项目
Natural Science Foundation of China["NSFC-81472367","NSFC-81871993","NSFC-81972766","NSFC-82173336","NSFC-81972420","NSFC-81773146"] ; Shenzhen Science and Technology Innovation Commission[JCYJ20190809161811237]
WOS研究方向
Cell Biology
WOS类目
Cell Biology
WOS记录号
WOS:000944246400005
出版者
来源库
Web of Science
引用统计
被引频次[WOS]:10
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/513415
专题南方科技大学医学院
作者单位
1.Southern Univ Sci & Technol, Sch Med, Shenzhen 518055, Peoples R China
2.Harbin Med Univ, Dept Immunol, Harbin, Peoples R China
3.Shanghai Univ Med & Hlth Sci, Chongming Hosp, Shanghai, Peoples R China
4.Fudan Univ, Zhongshan Hosp, Clin Ctr BioTherapy, Shanghai, Peoples R China
5.Fudan Univ, Zhongshan Hosp, Inst Biomed Sci, Shanghai, Peoples R China
6.Jiarun Hosp Harbin, Dept Ophthalmol, Harbin, Peoples R China
7.Guangxi Chinese Med Univ, Dept Microbiol & Immunol, Nanning, Peoples R China
8.Guangxi Key Lab Translat Med Treating High Inciden, Nanning, Peoples R China
9.Harbin Med Univ, Dept Colorectal Surg, Hosp 3, Harbin, Peoples R China
10.Guangdong Prov Key Lab Cell Microenvironm & Dis Re, Shenzhen, Guangdong, Peoples R China
第一作者单位南方科技大学医学院
通讯作者单位南方科技大学医学院
第一作者的第一单位南方科技大学医学院
推荐引用方式
GB/T 7714
Qiao, Ting,Yang, Wanli,He, Xiangchuan,et al. Dynamic differentiation of F4/80+tumor-associated macrophage and its role in tumor vascularization in a syngeneic mouse model of colorectal liver metastasis[J]. Cell Death & Disease,2023,14(2).
APA
Qiao, Ting.,Yang, Wanli.,He, Xiangchuan.,Song, Ping.,Chen, Xiao.,...&Ren, Huan.(2023).Dynamic differentiation of F4/80+tumor-associated macrophage and its role in tumor vascularization in a syngeneic mouse model of colorectal liver metastasis.Cell Death & Disease,14(2).
MLA
Qiao, Ting,et al."Dynamic differentiation of F4/80+tumor-associated macrophage and its role in tumor vascularization in a syngeneic mouse model of colorectal liver metastasis".Cell Death & Disease 14.2(2023).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Qiao, Ting]的文章
[Yang, Wanli]的文章
[He, Xiangchuan]的文章
百度学术
百度学术中相似的文章
[Qiao, Ting]的文章
[Yang, Wanli]的文章
[He, Xiangchuan]的文章
必应学术
必应学术中相似的文章
[Qiao, Ting]的文章
[Yang, Wanli]的文章
[He, Xiangchuan]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。